Studies

Neurology

Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378. English Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378. https://www.ncbi.nlm.nih.gov/pubmed/28478481 Neurology No 07/20/2017 4109 McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9. English McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9. http://www.plefa.com/article/S0952-3278(16)30219-8/fulltext Neurology No 06/01/2017 4118 Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interl English Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration. Eur J Nutr. 2017 May 18. https://link.springer.com/article/10.1007%2Fs00394-017-1462-7 Neurology No 05/25/2017 4121 Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594 English Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594.e5. doi: 10.1016/j.neuron.2017.03.043. Epub 2017 Apr 13. https://www.ncbi.nlm.nih.gov/pubmed/28416077 Neurology No 05/03/2017 3978 Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19. English Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259863/ Neurology Full text 01/24/2017 3910 Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13. English Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13. https://www.ncbi.nlm.nih.gov/pubmed/27881040 Neurology No 01/13/2017 3913

Amyotrophic lateral sclerosis

Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print] English Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26805387 Amyotrophic lateral sclerosis No 2016-01-12 00:00:00 3429

Autism

Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18. English Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18. https://www.ncbi.nlm.nih.gov/pubmed/28935269 Autism No 2017-09-18 00:00:00 4404 Sheppard KW, Boone KM, Gracious B, Klebanoff MA, Rogers LK, Rausch J, et al. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord. 2017 Jul 26. [Epub ahead of print] English Sheppard KW, Boone KM, Gracious B, Klebanoff MA, Rogers LK, Rausch J, et al. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord. 2017 Jul 26. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28748334 Autism No 2017-07-26 00:00:00 4329 Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. English Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. http://www.mdpi.com/1422-0067/16/5/10061/htm Autism Full text 2015-05-04 00:00:00 2530 Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. English Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463632/ Autism Full text 2015-05-04 00:00:00 2534 Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR. English Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR. http://www.ncbi.nlm.nih.gov/pubmed/25714424 Autism No 2015-04-15 00:00:00 2538 Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/e English Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/ejcn.2015.28. http://www.ncbi.nlm.nih.gov/pubmed/25804268 Autism No 2015-03-25 00:00:00 2537 Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146. English Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146. http://www.ncbi.nlm.nih.gov/pubmed/23800562 Autism No 2013-01-01 00:00:00 2524 Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54. English Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/pdf/10803_2010_Article_1078.pdf Autism Full text 2011-05-02 00:00:00 2529

Cognitive decline

Stilling F, Wolk A, Religa D, Leppert J, Bergkvist L, Michaëlsson K, et al. Adipose tissue fatty acid composition and cognitive impairment. Nutrition. 2018;54:153-7. English Stilling F, Wolk A, Religa D, Leppert J, Bergkvist L, Michaëlsson K, et al. Adipose tissue fatty acid composition and cognitive impairment. Nutrition. 2018;54:153-7. https://www.ncbi.nlm.nih.gov/pubmed/29982142 Cognitive decline No 2018-10-21 00:00:00 4825 McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, et al. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-56. English McNamara RK, Kalt W, Shidler MD, McDonald J, Summer SS, Stein AL, et al. Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment. Neurobiol Aging. 2018;64:147-56. https://www.sciencedirect.com/science/article/pii/S0197458017303974 Cognitive decline No 2018-10-21 00:00:00 4758 Pérez-Gálvez A, Jarén-Galán M, Garrido-Fernández J, Calvo MV, Visioli F, Fontecha J. Activities, bioavailability, and metabolism of lipids from structural membranes and oils: Promising research on mild cognitive impairment. Pharmacol Res. 2018 Jul 20;134: English Pérez-Gálvez A, Jarén-Galán M, Garrido-Fernández J, Calvo MV, Visioli F, Fontecha J. Activities, bioavailability, and metabolism of lipids from structural membranes and oils: Promising research on mild cognitive impairment. Pharmacol Res. 2018 Jul 20;134:299-304. https://www.ncbi.nlm.nih.gov/pubmed/30016644 Cognitive decline No 2018-10-21 00:00:00 4824 Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementat English Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation. FASEB J. 2017 Jan;31(1):148-160. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161513/ Cognitive decline Full text 2017-01-01 00:00:00 3944 Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print] English Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/27306037 Cognitive decline No 2016-06-13 00:00:00 3483 Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.11 English Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.1111/ggi.12691. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26822516 Cognitive decline No 2016-01-28 00:00:00 3486 Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print] English Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print] http://content.iospress.com/articles/journal-of-alzheimers-disease/jad150777 Cognitive decline Full text 2016-01-06 00:00:00 3487 Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with English Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2015 Oct 1. pii: S1053-8119(15)00872-1. http://www.ncbi.nlm.nih.gov/pubmed/26433119 Cognitive decline No 2015-10-01 00:00:00 3103 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. “Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial.” Am J Clin Nutr. 2015 Jul;102(1):215-21. English Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Cognitive decline No 2015-07-01 00:00:00 2548 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. English Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Cognitive decline No 2015-07-01 00:00:00 3168 Rathod RS, Khaire AA, Kale AA, Joshi SR. “Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats.” Abstract English Rathod RS, Khaire AA, Kale AA, Joshi SR. Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats. Biofactors. 2015 Jul-Aug;41(4):261-72. http://www.ncbi.nlm.nih.gov/pubmed/26249019 Cognitive decline No 2015-07-01 00:00:00 2533 Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. “An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.” J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-0 English Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-015-0395-y. http://www.ncbi.nlm.nih.gov/pubmed/25752887 Cognitive decline No 2015-06-01 00:00:00 2559 Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015. English Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015. http://www.ncbi.nlm.nih.gov/pubmed/25965872 Cognitive decline No 2015-04-28 00:00:00 2624 Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103 English Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103283. http://www.ncbi.nlm.nih.gov/pubmed/25877495 Cognitive decline No 2015-04-15 00:00:00 2617 Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/ English Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/j.pharep.2014.10.014. http://www.ncbi.nlm.nih.gov/pubmed/25712666 Cognitive decline No 2015-04-01 00:00:00 2614 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Ma English Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Mar 24. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Cognitive decline No 2015-03-24 00:00:00 2572 Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5. English Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344754/ Cognitive decline Full text 2015-01-01 00:00:00 2613 Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/136 English Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/13607863.2014.971705. Epub 2014 Nov 6. http://www.ncbi.nlm.nih.gov/pubmed/25374153 Cognitive decline No 2014-11-06 00:00:00 2579 Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4. English Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4. http://www.ncbi.nlm.nih.gov/pubmed/25316163 Cognitive decline No 2014-10-11 00:00:00 2580 Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014. English Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913863/ Cognitive decline Full text 2014-02-04 00:00:00 2592 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. English Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/ Cognitive decline Full text 2013-11-01 00:00:00 2630 O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P English O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript. http://www.ncbi.nlm.nih.gov/pubmed/24342530 Cognitive decline No 2013-10-03 00:00:00 2601 O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P English O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript. http://www.sciencedirect.com/science/article/pii/S0899900713004450 Cognitive decline No 2013-10-01 00:00:00 2623 Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24. English Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24. http://www.ncbi.nlm.nih.gov/pubmed/23796946 Cognitive decline No 2013-06-24 00:00:00 2605 Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94. English Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94. http://www.ncbi.nlm.nih.gov/pubmed/23395782 Cognitive decline No 2013-03-12 00:00:00 2591 Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5. English Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738731/ Cognitive decline Full text 2012-07-16 00:00:00 2585 Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11 English Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf Cognitive decline Full text 2012-01-01 00:00:00 2598 Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249. English Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280054/ Cognitive decline Full text 2012-01-01 00:00:00 2588 Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664. English Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664. http://www.neurology.org/content/78/9/658 Cognitive decline No 2012-01-01 00:00:00 2602 Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-65 English Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-650. http://www.neurology.org/content/79/7/642 Cognitive decline No 2012-01-01 00:00:00 2629 Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25. English Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055780/ Cognitive decline No 2010-12-01 00:00:00 2597 Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. English Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010 Cognitive decline No 2010-11-06 00:00:00 2606 Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9. English Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061499/ Cognitive decline Full text 2010-11-01 00:00:00 2609 Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. English Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013. http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010 Deterioro cognitivo No 2010-01-13 00:00:00 2633 Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657. English Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657. http://www.ncbi.nlm.nih.gov/pubmed/16212510 Cognitive decline No 2005-01-01 00:00:00 2618 Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33. English Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33. http://www.ncbi.nlm.nih.gov/pubmed/8323999 Deterioro cognitivo No 1993-01-01 00:00:00 2610

Cystic fibrosis

Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249. English Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291435/pdf/pone.0171249.pdf Cystic fibrosis Full text 2017-07-12 00:00:00 4254 Eickmeier O, Fussbroich D, MuellerK, Serve F, Smaczny C, Zielen S, Schubert R, Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 February 3 English Eickmeier O, Fussbroich D, MuellerK, Serve F, Smaczny C, Zielen S, Schubert R, Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 February 3 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171249 Fibrosis quística Full text 2017-05-31 00:00:00 4030 Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.01 English Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.014. Epub 2016 Mar 28. http://www.ncbi.nlm.nih.gov/pubmed/27154364 Cystic fibrosis No 2016-03-28 00:00:00 3413 Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print] English Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26730723 Cystic fibrosis No 2016-01-05 00:00:00 3416

Dementia and Alzheimer

van Lent DM, Weinhold L, Wolfsgruber S, Schmid M, Maier W, Jessen F, et al. Eicosapentanoic acid but not docosahexaenoic acid is associated with Alzheimer's disease risk in the oldest old. Presented at: 2018 Alzheimer's Association International Conferenc English van Lent DM, Weinhold L, Wolfsgruber S, Schmid M, Maier W, Jessen F, et al. Eicosapentanoic acid but not docosahexaenoic acid is associated with Alzheimer's disease risk in the oldest old. Presented at: 2018 Alzheimer's Association International Conference. July 22-26, 2018; Chicago, IL. Abstract 22855 https://ep70.eventpilotadmin.com/web/planner.php?id=AAIC18 Dementia and Alzheimer No 2018-10-21 00:00:00 4827 Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke. J Clin Neurol. 2018;14(1):29-34. English Shang J, Yamashita T, Fukui Y, Song D, Li X, Zhai Y, et al. Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke. J Clin Neurol. 2018;14(1):29-34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765253/ Dementia and Alzheimer No 2018-10-21 00:00:00 4714 Derbyshire E. Brain health across the lifespan: a systematic review on the role of omega-3 fatty acid supplements. Nutrients. 2018 Aug 15;10(8). English Derbyshire E. Brain health across the lifespan: a systematic review on the role of omega-3 fatty acid supplements. Nutrients. 2018 Aug 15;10(8). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116096/ Dementia and Alzheimer No 2018-10-21 00:00:00 4826 Zhu M, Wang X, Hjorth E, et al. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol. 2016;53(4):2733-49. English Zhu M, Wang X, Hjorth E, et al. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis. Mol Neurobiol. 2016;53(4):2733-49. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824659/ Dementia and Alzheimer No 2018-10-01 00:00:00 4617 Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando English Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681480/ Demencia y Alzheimer No 2017-11-06 00:00:00 4429 Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Le English Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Leukot Essent Fatty Acids. 2017;121:68-75. https://www.ncbi.nlm.nih.gov/pubmed/28651700 Dementia and Alzheimer No 2017-06-21 00:00:00 4333 Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078. English Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078. https://www.ncbi.nlm.nih.gov/pubmed/28733268 Dementia and Alzheimer No 2017-06-15 00:00:00 4334 Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20. English Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20. http://www.jlr.org/content/early/2017/05/20/jlr.R076331.full.pdf Dementia and Alzheimer Full text 2017-05-31 00:00:00 4156 Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18. English Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18. https://www.ncbi.nlm.nih.gov/pubmed/28420693 Dementia and Alzheimer No 2017-05-01 00:00:00 4155 Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347. English Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347. https://www.ncbi.nlm.nih.gov/pubmed/28114437 Dementia and Alzheimer No 2017-03-01 00:00:00 3947 Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293. English Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293. https://www.ncbi.nlm.nih.gov/pubmed/27789520 Dementia and Alzheimer No 2017-01-01 00:00:00 3950 Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9. English Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127208/ Dementia and Alzheimer Full text 2017-01-01 00:00:00 3954 Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542 English Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542. https://www.ncbi.nlm.nih.gov/pubmed/27813426 Dementia and Alzheimer No 2016-12-01 00:00:00 3953 Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11. English Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11. https://www.ncbi.nlm.nih.gov/pubmed/27825512 Dementia and Alzheimer No 2016-12-01 00:00:00 3949 Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fa English Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study. J Alzheimers Dis. 2015 Oct 1;48(3):805-12. http://www.ncbi.nlm.nih.gov/pubmed/26402079 Dementia and Alzheimer No 2015-10-01 00:00:00 3106 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. English Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Dementia and Alzheimer No 2015-07-01 00:00:00 2569 Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81. English Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81. http://www.ncbi.nlm.nih.gov/pubmed/26085639 Dementia and Alzheimer No 2015-06-17 00:00:00 2563 Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218. English Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218. http://www.ncbi.nlm.nih.gov/pubmed/25805829 Dementia and Alzheimer No 2015-03-24 00:00:00 2640 Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers D English Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886557/ Dementia and Alzheimer Full text 2014-01-01 00:00:00 2653 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. English Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/ Dementia and Alzheimer Full text 2013-11-01 00:00:00 2654 Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816. English Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016440/pdf/pone.0015816.pdf Dementia and Alzheimer Full text 2011-01-05 00:00:00 2659 Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18. English Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18. http://revistaalzheimer.com/PDF/0239.pdf Dementia and Alzheimer Full text 2011-01-01 00:00:00 2637 Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17) English Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17):1903-11. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259852/ Dementia and Alzheimer Full text 2010-11-03 00:00:00 2650 Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61. English Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61. https://www.dovepress.com/getfile.php?fileID=5956 Dementia and Alzheimer Full text 2010-04-07 00:00:00 2646 Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52. English Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52. http://www.ncbi.nlm.nih.gov/pubmed/19262590 Dementia and Alzheimer No 2009-03-05 00:00:00 2643 Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71. English Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71. http://www.ncbi.nlm.nih.gov/pubmed/18050989 Dementia and Alzheimer No 2007-10-31 00:00:00 2649

Epilepsy

Ibrahim FAS, Ghebremeskel K, Abdel-Rahman ME, Ahmed AAM, Mohmed IM, Osman G, et al. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double English Ibrahim FAS, Ghebremeskel K, Abdel-Rahman ME, Ahmed AAM, Mohmed IM, Osman G, et al. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial. Epilepsy Behav. 2018;87:32-8. https://www.ncbi.nlm.nih.gov/pubmed/30170260 Epilepsy No 2018-10-21 00:00:00 4803 Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print] English Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26845549 Epilepsy No 2016-02-04 00:00:00 3409 Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002. English Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002. http://www.ncbi.nlm.nih.gov/pubmed/25725327 Epilepsy No 2015-02-25 00:00:00 3020 Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2. English Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2. http://www.ncbi.nlm.nih.gov/pubmed/18992844 Epilepsy No 2008-12-02 00:00:00 3023 Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83. English Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83. http://www.ncbi.nlm.nih.gov/pubmed/18511348 Epilepsy No 2008-08-01 00:00:00 3019

Memory

Zamroziewicz MK, Paul EJ, Zwilling CE, et al. Predictors of Memory in Healthy Aging: Polyunsaturated Fatty Acid Balance and Fornix White Matter Integrity. Aging Dis. 2017 Jul 21;8(4):372-83. English Zamroziewicz MK, Paul EJ, Zwilling CE, et al. Predictors of Memory in Healthy Aging: Polyunsaturated Fatty Acid Balance and Fornix White Matter Integrity. Aging Dis. 2017 Jul 21;8(4):372-83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524800/ Memory Full text 2017-07-21 00:00:00 4413 Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print] English Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26890759 Memory No 2016-02-10 00:00:00 3491 Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6. English Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6. http://www.ncbi.nlm.nih.gov/pubmed/26812512 Memory No 2016-02-01 00:00:00 3490 Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62. English Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62. http://www.ncbi.nlm.nih.gov/pubmed/26321578 Memory No 2015-10-01 00:00:00 3102 Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11 English Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf Memory Full text 2012-01-01 00:00:00 2566 Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010 English Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-74. http://www.ncbi.nlm.nih.gov/pubmed/20523044 Memory No 2010-01-01 00:00:00 2571 Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9. English Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9. http://www.ncbi.nlm.nih.gov/pubmed/17368750 Memory No 2007-01-01 00:00:00 2565